These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2169973)

  • 21. Tat-induced lesions in transgenic mice do not correlate with the HIV-1 LTR transactivation.
    Fergelot P; Molina T; Blanchet P; Grimber G; Duquenne O; Couton D; Zider A; Briand P; Cavard C
    C R Acad Sci III; 1995 Mar; 318(3):329-37. PubMed ID: 7788501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum.
    Bansal AK; Mactutus CF; Nath A; Maragos W; Hauser KF; Booze RM
    Brain Res; 2000 Oct; 879(1-2):42-9. PubMed ID: 11011004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro.
    Gurwell JA; Nath A; Sun Q; Zhang J; Martin KM; Chen Y; Hauser KF
    Neuroscience; 2001; 102(3):555-63. PubMed ID: 11226693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute in vivo neurotoxicity of peptides from Maedi Visna virus transactivating protein Tat.
    Starling I; Wright A; Arbuthnott G; Harkiss G
    Brain Res; 1999 Jun; 830(2):285-91. PubMed ID: 10366685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The maedi-visna virus Tat protein induces multiorgan lymphoid hyperplasia in transgenic mice.
    Vellutini C; Philippon V; Gambarelli D; Horschowski N; Nave KA; Navarro JM; Auphan M; Courcoul MA; Filippi P
    J Virol; 1994 Aug; 68(8):4955-62. PubMed ID: 8035494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virus.
    Strijbos PJ; Zamani MR; Rothwell NJ; Arbuthnott G; Harkiss G
    Neurosci Lett; 1995 Sep; 197(3):215-8. PubMed ID: 8552302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement.
    Jones M; Olafson K; Del Bigio MR; Peeling J; Nath A
    J Neuropathol Exp Neurol; 1998 Jun; 57(6):563-70. PubMed ID: 9630236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a cDNA clone encoding the visna virus transactivating protein.
    Davis JL; Clements JE
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):414-8. PubMed ID: 2536163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.
    Khan NA; Di Cello F; Nath A; Kim KS
    J Neurovirol; 2003 Dec; 9(6):584-93. PubMed ID: 14602571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors.
    Johnston JB; Zhang K; Silva C; Shalinsky DR; Conant K; Ni W; Corbett D; Yong VW; Power C
    Ann Neurol; 2001 Feb; 49(2):230-41. PubMed ID: 11220743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous cocaine abuse: a rodent model for potential interactions with HIV proteins.
    Bansal AK; Mactutus CF; Nath A; Anderson C; Booze RM
    Adv Exp Med Biol; 2001; 493():241-5. PubMed ID: 11727772
    [No Abstract]   [Full Text] [Related]  

  • 32. CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates.
    El-Hage N; Wu G; Ambati J; Bruce-Keller AJ; Knapp PE; Hauser KF
    J Neuroimmunol; 2006 Sep; 178(1-2):9-16. PubMed ID: 16831471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins.
    Rumbaugh JA; Li G; Rothstein J; Nath A
    J Neurovirol; 2007 Apr; 13(2):168-72. PubMed ID: 17505985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression in Escherichia coli of an immunoreactive visna virus transactivating protein.
    Watson G; Harkiss GD
    Gene; 1990 Oct; 94(2):237-41. PubMed ID: 2175280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tat contains a sequence related to snake neurotoxins.
    Garry RF; Koch G
    AIDS; 1992 Dec; 6(12):1541-2. PubMed ID: 1492938
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.
    Nookala AR; Shah A; Noel RJ; Kumar A
    PLoS One; 2013; 8(11):e78855. PubMed ID: 24244375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Tat protein in HIV neuropathogenesis.
    Li W; Li G; Steiner J; Nath A
    Neurotox Res; 2009 Oct; 16(3):205-20. PubMed ID: 19526283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?
    Campbell GR; Loret EP
    Retrovirology; 2009 May; 6():50. PubMed ID: 19467159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methods to study monocyte migration induced by HIV-infected cells.
    Rao VR; Eugenin EA; Berman JW; Prasad VR
    Methods Mol Biol; 2009; 485():295-309. PubMed ID: 19020833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 clade-specific differences in the induction of neuropathogenesis.
    Rao VR; Sas AR; Eugenin EA; Siddappa NB; Bimonte-Nelson H; Berman JW; Ranga U; Tyor WR; Prasad VR
    J Neurosci; 2008 Oct; 28(40):10010-6. PubMed ID: 18829958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.